Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:364-365 (11 February), doi:10.1136/bmj.332.7537.364-c
| The first 150 words of the full text of this article appear below. |
EDITORFurness makes an important point about the lack of emphasis on diagnostics but ironically has the wrong diagnosis.1 As we tried to make clear in our editorial,2 there is a long chain from health technology assessment (the scientific summation of evidence about effectiveness) through appraisal (the policy related judgments that the National Institute for Health and Clinical Excellence (NICE) and others then make on the basis of the assessments) to the implementation and availability of services. The neglect of diagnostics lies not with health technology assessment but further along the chain.
The NHS programme for health technology assessment has given much attention to diagnostics. Although health technology assessment covers all healthcare interventions from health promotion through disease prevention, diagnosis, treatment, and rehabilitation through to continuing care, the programme has devoted one of its four expert panels (until this year, one of only three) entirely to diagnostics and screening.
John Gabbay, professor emeritus1, Tom Walley, professor of clinical pharmacology2
1 Wessex Institute for Health Research and Development, University of Southampton SO16 7PX jg3@soton.ac.uk, 2 Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3GF